Guidance on the use of electroconvulsive therapy.
Guidance on the use of electroconvulsive therapy.
1 April 2003
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]
Summary,
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]
Summary,
GUIDELINE OBJECTIVE(S)
To establish the clinical and cost effectiveness of electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia, and mania
TARGET POPULATION
Adults with depressive illness, schizophrenia, catatonia, or mania
INTERVENTIONS AND PRACTICES CONSIDERED
Electroconvulsive therapy
MAJOR OUTCOMES CONSIDERED
* Clinical effectiveness
o Symptom improvement
o Quality of life
o Adverse effects
* Cost effectiveness
Specialities:
- Neurology
- ADHD
- Advanced Parkinson's Disease
- Anxiety Disorder
- Brain Cancer
- Cerebrovascular Disease
- Dementia
- Epilepsy
- Mood Disorders
- Motor/Movement Disorder
- Multiple Sclerosis
- Neuroimaging
- Neurosurgery
- Obsessive-Compulsive Disorder
- Pain/Headache
- Parkinson's Disease
- Psychiatry
- Schizophrenia
- Sleep Disorder
- Stroke
- 16 February 2012
- 1 March 2012
- 1 March 2012










